Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- COPEIndependent statistical analysis of A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- COPE-HCVIndependent statistical analysis of Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: Complete Statistical AnalysisIndependent statistical analysis of CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00889265).
- Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662060).
- COPPSIndependent statistical analysis of COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04662073).
- CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Corneal Nerves Function and Structure: Complete Statistical AnalysisIndependent statistical analysis of Corneal Nerves Function and Structure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222660).
- Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: Complete Statistical AnalysisIndependent statistical analysis of Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00353795).
- Coronary MDCTA With Iopamidol Injection 370: Complete Statistical AnalysisIndependent statistical analysis of Coronary MDCTA With Iopamidol Injection 370: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00558792).
- CorPath® GRX Neuro Study: Complete Statistical AnalysisIndependent statistical analysis of CorPath® GRX Neuro Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04236856).
- Cortical Contributions to Motor Sequence Learning: Complete Statistical AnalysisIndependent statistical analysis of Cortical Contributions to Motor Sequence Learning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04138953).
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: Complete Statistical AnalysisIndependent statistical analysis of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227980).
- Cortisol Response to Moderate and Deep Sedation in Children: Complete Statistical AnalysisIndependent statistical analysis of Cortisol Response to Moderate and Deep Sedation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265966).
- COSMOSIndependent statistical analysis of A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- COSMOSIndependent statistical analysis of A Study in Participants With Non-cirrhotic NASH With Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638737).
- COSMOS-MindIndependent statistical analysis of COcoa Supplement and Multivitamin Outcomes Study for the Mind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03035201).
- Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: Complete Statistical AnalysisIndependent statistical analysis of Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COU-AA-301Independent statistical analysis of COU-AA-301, a randomized phase 3 trial of abiraterone acetate in castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy, covering overall survival, progression, PSA response, trial design, and statistical…
- COUGH-1Independent statistical analysis of Safety and Tolerability of COVID-19 Vaccine (ABNCoV2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04839146).
- COV-BARRIERComplete statistical analysis of the COV-BARRIER phase 3 trial of baricitinib plus standard of care versus placebo plus standard of care in participants with COVID-19, including trial design, endpoints, statistical methodology, reported…
- COVACTAIndependent statistical analysis of the randomized phase 3 COVACTA trial evaluating tocilizumab versus placebo in patients with severe COVID-19 pneumonia, including endpoint definitions, reported treatment effects, confidence intervals, p-values, and statistical methodology.
- COVACTAIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- COVENANTIndependent statistical analysis of HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CoverEdge Algorithm Programming Study: Complete Statistical AnalysisIndependent statistical analysis of CoverEdge Algorithm Programming Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02492880).
- COVID SAFE 2Independent statistical analysis of COVID-19 Screening Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216627).
- COVID-19Complete statistical analysis of the randomized phase 3 COLCORONA trial of colchicine versus placebo in ambulatory patients with Corona Virus Infection, including trial design, endpoints, statistical methods, reported results, safety, and interpretation.
- COVID-19Independent statistical analysis of Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05973006).
- COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05584189).
- COVID-19 PEPComplete statistical analysis of the randomized phase 3 COVID-19 PEP trial of hydroxychloroquine versus placebo for post-exposure prophylaxis and preemptive therapy for SARS-CoV-2.
- COVID-19 PrEP HCW HCQ Study: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 PrEP HCW HCQ Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04354870).
- COVID-19 Project ECHO in Nursing Homes: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Project ECHO in Nursing Homes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499391).
- COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06547814).
- COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): Complete Statistical AnalysisIndependent statistical analysis of COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04595773).
- COVID-AntibodyIndependent statistical analysis of Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04334876).
- COVIDX_EVCDAOIndependent statistical analysis of Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COViNOXIndependent statistical analysis of A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COVIPACT 2Independent statistical analysis of Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- COZIIndependent statistical analysis of CBT-I or Zolpidem/Trazodone for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468776).
- CP-690-550 Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of CP-690-550 Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01246583).
- CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01653158).
- CPAP to Treat Cognitive Dysfunction in MS: Complete Statistical AnalysisIndependent statistical analysis of CPAP to Treat Cognitive Dysfunction in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544373).
- CPCIndependent statistical analysis of Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CPEX-011Independent statistical analysis of Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPIT001Independent statistical analysis of Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: primary endpoint results, effect estimate with confidence interval,…
- CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: Complete Statistical AnalysisIndependent statistical analysis of CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cranberry Effect on Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of Cranberry Effect on Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02996981).